Shanghai WiseGain Medical Devices Co., Ltd.   Report issue

For profit Phase 3
Founded: Shanghai China (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2016
NCT02900729
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

amlodipine (norvasc) (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

losartan (cozaar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3